Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

9.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.4K
Ligand Binding Sites02:40

Ligand Binding Sites

14.1K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep docking, part 2: an amplified DDU platform for ultra-large virtual screening.

Chemical science·2026
Same author

Covalent Inhibitors of Monoacylglycerol Lipase Induce Conformational Changes and Proteasomal Degradation.

Journal of the American Chemical Society·2026
Same author

The Use of DeepQSAR Models for the Discovery of Peptides With Enhanced Antimicrobial and Antibiofilm Potential.

Molecular informatics·2026
Same author

Retraction of "The Use of DeepQSAR Models for The Discovery of Peptides with Enhanced Antimicrobial and Antibiofilm Potential".

Journal of chemical information and modeling·2026
Same author

Pharmacokinetics, pathology and efficacy of SARS-CoV-2 main protease inhibitor VPC285785 in a murine model of coronavirus infection.

Scientific reports·2026
Same author

CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2.

Journal of chemical information and modeling·2026

Related Experiment Video

Updated: Oct 13, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

613

DD-GUI: a graphical user interface for deep learning-accelerated virtual screening of large chemical libraries (Deep

Jean Charle Yaacoub1, James Gleave1, Francesco Gentile1

  • 1Vancouver Prostate Centre, Department of Urologic Sciences, The University of British Columbia, Vancouver, BC V6H 3Z6, Canada.

Bioinformatics (Oxford, England)
|November 17, 2021
PubMed
Summary

Deep learning (DL) accelerates virtual screening of large chemical libraries. The new Deep Docking Graphical User Interface (DD-GUI) simplifies setup, progress tracking, and outcome analysis for drug discovery projects.

More Related Videos

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
05:00

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

1.5K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.7K

Related Experiment Videos

Last Updated: Oct 13, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

613
Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
05:00

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

1.5K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.7K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Bioinformatics

Background:

  • Virtual screening of ultra-large chemical libraries is computationally intensive.
  • Deep learning (DL) offers a promising approach to accelerate this process.
  • Existing DL methods for virtual screening require technical expertise for implementation.

Purpose of the Study:

  • To introduce DD-GUI, a graphical user interface for the Deep Docking (DD) deep learning approach.
  • To enable intuitive and efficient setup of large-scale virtual screening campaigns.
  • To provide tools for tracking progress and analyzing results in drug discovery projects.

Main Methods:

  • Development of a user-friendly graphical interface (DD-GUI) for the Deep Docking (DD) deep learning model.
  • Integration of features for streamlined virtual screening setup.
  • Implementation of progress monitoring and outcome analysis tools.

Main Results:

  • DD-GUI facilitates rapid setup of virtual screening for billions of compounds.
  • The interface simplifies the application of deep learning for accelerated drug discovery.
  • Users can intuitively track screening progress and analyze results.

Conclusions:

  • DD-GUI significantly enhances the accessibility and usability of deep learning for virtual screening.
  • This tool accelerates the evaluation of large chemical libraries, reducing computational cost and time.
  • DD-GUI supports efficient drug discovery workflows by simplifying complex computational tasks.